AMPLIFY PHARMA: Integrating Automation to Accelerate Financial Growth
Customer expectations and Safety has become the buzzword today for every stakeholder in the Pharma Industry. All are making their business processes and functions automated to fuel the financial growth. We see an increasing number of pharmaceutical firms and indeed, medical device companies – are partnering and integrating with technology businesses.
Now the worry is how do the pharma industry stay relevant in front of consumers while maintaining their financial growth? With the emergence of exponential technologies such as Robotic Process Automation (RPA), Artificial Intelligence and Analytics, the sector is witnessing a paradigm shift affecting business processes today. RPA is of greatest value when used for rule-based, repetitive processes in drug development operations. Its use can support consistency in data entry, quality control and audit readiness in several targeted activities comprising clinical, regulatory, safety and laboratory operations.
Digital and analytics tools and automation will be the engines that accelerate agility and transparency. Digital tools will also enable some key business processes—such as auditing or product release—to be done remotely, potentially decreasing the risk of disruption while improving efficiencies.